Statement

FDA Recall of Medications

"Houston Medical Center was notified October 18th regarding the second recall of medication by the U.S. Food and Drug Administration (FDA) that was made and distributed by the New England Compounding Company (NECC).

During the first recall of steroid injections produced by NECC, Houston Medical Center was not identified by the FDA as a facility receiving these medications.

It is our understanding the FDA has now recalled all medications manufactured by NECC. Houston Medical Center did purchase a very small quantity of two medications – Potassium Phosphate and Sodium Phosphate – from NECC during September and October 2011, due to a shortage with our normal supplier. These medications have not been linked to any known infection and were also dispensed prior to May 21, 2012, the recommended date for follow-up by the FDA. We will continue to monitor the information released from the FDA regarding the situation."

Cary Martin

Chief Executive Officer

Contact:

Priscilla Kennedy

Public Relations & Marketing Specialist

(478) 542-7744

(478) 954-6190 cell

pkennedy@hhc.org